V017-3120 Screening compound: ethyl 1-[4-(2-fluorobenzamido)-2-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate

V017-3120 Screening compound: ethyl 1-[4-(2-fluorobenzamido)-2-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate
V017-3120 Screening compound: ethyl 1-[4-(2-fluorobenzamido)-2-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-3120
ethyl 1-[4-(2-fluorobenzamido)-2-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-3120

Molecular Formula

C31H34FN3O5S (C31 H34 FN3 O5 S)

Compound Name

ethyl 1-[4-(2-fluorobenzamido)-2-[(1,2,3,4-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate

IUPAC name

ethyl 1-[4-(2-fluorobenzamido)-2-[(1234-tetrahydronaphthalen-1-yl)sulfamoyl]phenyl]piperidine-4-carboxylate

SMILES

CCOC(C(CC1)CCN1c(ccc(NC(c(cccc1)c1F)=O)c1)c1S(NC(CCC1)c2c1cccc2)(=O)=O)=O

InChI

InChI=1S/C31H34FN3O5S/c1-2-40-31(37)22-16-18-35(19-17-22)28-15-14-23(33-30(36)25-11-5-6-12-26(25)32)20-29(28)41(38,39)34-27-13-7-9-21-8-3-4-10-24(21)27/h3-6,8,10-12,14-15,20,22,27,34H,2,7,9,13,16-19H2,1H3,(H,33,36)/t27-/m0/s1

InChI Key

DGHJGNXUVIZHOU-MHZLTWQESA-N

MDL Number (MFCD)

MFCD19972664

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

579.69

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.811

Distribution Coefficient, logD

5.752

Water Solubility, LogSw

-5.41

Polar Surface Area

89.050

Acid Dissociation Constant (pKa)

8.24

Base Dissociation Constant (pKb)

7.14

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.50

V017-3120 in Drug Discovery

Included in Screening Libraries

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V017-3120 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-3120?
Check Price and Availability of V017-3120, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-3120 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-3120
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-3120
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-3120 available by request